It was the day's biggest move, and it came from ARKK. The rest of the day's trades, plus ARK's scorecard against the S&P 500.

Generated from ARK's own holdings data.
On 8 Oct 2026, Cathie Wood sold an estimated $26.7M of Intellia Therapeutics Inc (NTLA) across ARKK. It topped everything else ARK did that session.
Every other holding grew by about 20.3% that day as money came into the funds. This position shrank by 20% — the gap is what makes it a deliberate trade rather than cash being spread across the portfolio.
It is part of a pattern: over the last 30 days ARK is a net seller of Intellia Therapeutics Inc, $46.6M across 25 trades.
ARK made 23 real moves that day, once money flowing in and out of the funds is stripped out:
| Stock | Funds | Est. value |
|---|---|---|
| NTLA Intellia Therapeutics Inc | ARKK | −$26.7M |
| HOOD Robinhood Markets Inc | ARKK | −$16.6M |
| CRWV CoreWeave Inc | ARKK | +$12.6M |
| PSNL Personalis Inc | ARKG | −$12.0M |
| TER Teradyne Inc | ARKQ and ARKX | −$11.1M |
| KTOS Kratos Defense & Security | ARKK | +$8.8M |
Over the last 30 days ARK's biggest net buys have been Nvidia Corp ($81.0M), Meta Platforms Inc ($75.9M), CoreWeave Inc ($53.9M). Meanwhile the funds have been trimming Advanced Micro Devices ($130.3M), 10X Genomics Inc ($79.4M), Twist Bioscience Corp ($49.1M).
This year ARKK is behind the market — +14.8% against +14.9% for the S&P 500.
The last 12 months tell a different story — ARKK -0.9% versus the index's +17.4%, a 18-point gap.
That five-year gap — 110 points — mostly comes down to timing. Five years ago ARKK was trading close to its all-time high of Feb 2021. It then fell 81% to its low in Dec 2022, and it is still 43% below that peak today. Any comparison that starts near the top of that boom looks brutal.
| To date | 1 month | YTD | 1 year | 5 years |
|---|---|---|---|---|
| ARKK | +2.4% | +14.8% | -0.9% | -20.3% |
| S&P 500 (SPY) | +1.2% | +14.9% | +17.4% | +89.4% |
| Nasdaq-100 (QQQ) | +5.5% | +23.6% | +25.8% | +114.9% |
ETFpeek is an independent research tool and is not affiliated with ARK Invest or Cathie Wood. Figures are estimates from public fund data, shown for information only — not financial advice. Past performance does not indicate future results.